(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CONTENT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CONTENT

ST13

US500000079198702

Class

42

Filing

79198702

Registration

5348222

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

07/16/2026

Trademark type

Combined

Nice classes

42

Filing date

09/06/2016

Registration date

12/05/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/21/2024

Last transaction

07/16/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

Wrexham, GB

Examiner

GILLES, DEBORAH LYNN MEINERS

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "CONTENT" with the "CON" and "ENT" in black and the first "T" in green; the vertical portion of first "T" in green extends downward and has one green leaf on each side of it.

Holders and representatives

Holders

IPSEN BIOPHARM LIMITED

Representatives

G MATHEW LOMBARD LOMBARD & GELIEBTER LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for pharmaceutical products for others

Publications

History of USPTO decisions and trademark events.

29 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

07/16/2026

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

06/06/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

05/07/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

05/07/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

02/21/2025

C71T

CANCELLED SECTION 71

06/21/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/05/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/11/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/20/2018

FIMP

FINAL DISPOSITION PROCESSED

03/20/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/05/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/19/2017

PUBO

PUBLISHED FOR OPPOSITION

09/19/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/30/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/11/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/08/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/08/2017

ALIE

ASSIGNED TO LIE

08/06/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/10/2017

RFNT

REFUSAL PROCESSED BY IB

01/27/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/11/2017

RFRR

REFUSAL PROCESSED BY MPU

01/11/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/04/2017

CNRT

NON-FINAL ACTION WRITTEN

01/03/2017

MAFR

APPLICATION FILING RECEIPT MAILED

12/31/2016

DOCK

ASSIGNED TO EXAMINER

12/27/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/27/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/22/2016

Continuous trademark protection

Get notified about every new filing that threatens CONTENT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.